Get started
Author

Gülten Korkmaz

Observed names: G. Korkmaz, Gulten Korkmaz, Gülten KORKMAZ, KORKMAZ, GULTEN, KORKMAZ, GÜLTEN, Korkmaz, Gülten, korkmaz, gülten
ORCID: 0000-0003-4467-9724
Observed ORCID: 0000-0003-4467-9724
OpenAlex ID: A5022317430
The Real‐World Experience With Single Agent Ibrutinib in Relapsed/Refractory CLL
2021 · Seval Akpinar, Mehmet Hilmi Dogu, et al. · Clinical Lymphoma Myeloma & Leukemia · 8
Effectiveness of ibrutinib in the management of chronic GVHD
2024 · Mehmet Ali Erkurt, Ahmet Sarici, et al. · Transfusion and Apheresis Science · 6
PDF
BNT162b2 or CoronaVac as the Third Dose against Omicron: Neutralizing Antibody Responses among Transplant Recipients Who Had Received Two Doses of CoronaVac
2023 · Çiğdem Erol, Zeynep Ece Kuloğlu, et al. · Viruses · 4
PDF
The Relationship of Neutrophil Lymphocyte Ratio With Prognosis and Disease Activity in Patients With Rheumatoid Arthritis
2022 · Gülten KORKMAZ, Mustafa ÖZMEN, et al. · Cumhuriyet Tıp Dergisi/Cumhuriyet Üniversitesi Tıp Fakültesi dergisi · 3
PDF
Does body mass index affect stem cell yield in healthy donors?
2025 · Seda Yilmaz, Nazik Okumus, et al. · Transfusion and Apheresis Science · 1
Are mesenchymal stem cells still effective in acute GvHD management?
2024 · Bahar Uncu Ulu, Ipek Yonal Hindilerden, et al. · Transfusion and Apheresis Science · 1
PDF
Steroid-associated hypofibrinogenemia: an overlooked risk in graft-versus-host disease management after allogeneic hematopoietic stem cell transplantation
2026 · Fahir Ozturk, Gulten Korkmaz, et al. · Blood Coagulation & Fibrinolysis
De novo development of JAK2V617F-positive polycythemia vera following allogeneic hematopoietic stem cell transplantation: a report of two rare cases
2026 · Gulten Korkmaz · Upsala Journal of Medical Sciences
PDF
FACIT-fatigue score and treatment quality assessment for paroxysmal nocturnal hemoglobinuria patients treated with Eculizumab in Türkiye
2026 · Zehra Narlı Özdemir, Fatma Keklik Karadağ, et al. · PLoS ONE
PDF
Real-world data on the use of asciminib in chronic-phase chronic myeloid leukemia after two or more prior tyrosine kinase inhibitors: Results of the Turkish managed access program along with a literature review
2026 · Deniz Özmen, Derya Deniz Kürekçi, et al. · Leukemia Research
Ruxolitinib-Treated Myeloproliferative Neoplasms: Real-World Infectious Outcomes and Preventive Practices from a Single Center
2026 · Muruvvet Seda Aydin, Gulten Korkmaz, et al. · Mediterranean Journal of Hematology and Infectious Diseases
PDF
Dramatic Response to Elranatamab in a Patient with Large Plasmacytomas
2026 · Gülten Korkmaz · Turkish Journal of Hematology
PDF
Comparison of Peripheral Stem Cell Mobilization Results on the Fourth and Fifth Day of G‐CSF Treatment in Unrelated Donors
2026 · Gulten Korkmaz, Gulsum Ozet, et al. · Journal of Clinical Apheresis
Clinical Associations of Osteoporosis in BCR::ABL1 Negative Myeloproliferative Neoplasms
2026 · Mürüvvet Seda Aydin, Simten Dagdas, et al. · International Journal of Endocrinology
PDF
Akut Miyeloid Lösemi Hastalarında Kemik İliği Fibrozisinin Sağkalım Üzerine Olan Etkisi
2025 · Mehmet Sezgin PEPELER, Merve PAMUKÇUOĞLU, et al. · LLM Dergi
PDF
Relaps/Refrakter Germ Hücreli Testis Tümörlerinde Yüksek Doz Kemoterapi ve Otolog Kök Hücre Nakil Sonuçları: Tek Merkez Deneyimi
2025 · Gülten KORKMAZ, Doğan BAYRAM, et al. · LLM Dergi
PDF
POSTER: CT-376 Does Body Mass Index Affect Stem Cell Yield in Healthy Donors?
2025 · Ugur Hatipoglu, Seda Yılmaz, et al. · Clinical Lymphoma Myeloma & Leukemia
CT-376: Does Body Mass Index Affect Stem Cell Yield in Healthy Donors?
2025 · Ugur Hatipoglu, Seda Yılmaz, et al. · Clinical Lymphoma Myeloma & Leukemia
Pb1897: Gilteritinib in Turkey: Early Access Program Results
2023 · Mehmet Hilmi Dogu, Ali Irfan Emre Tekgunduz, et al. · HemaSphere
Pb2449: Effect of Mobilization Methods on Cd34+ and Total Nucleated Cell Count and Their Relation With Engraftment in Autologous Hematopoietic Stem Cell Transplantation
2023 · Ozlem Beyler, Merve Pamukçuoğlu, et al. · HemaSphere
P1343: Transplant Outcomes of Lymphoma Patients Undergoing Stem Cell Mobilization With Plerixafor
2022 · A. K. Gunes, S. Dagdas, et al. · HemaSphere
Impact of Bone Marrow Fibrosis in Myeloma Patients Undergone Autologous Stem Cell Transplantation
2021 · Senem Maral, Murat Albayrak, et al. · Hematology Transfusion and Cell Therapy
PDF
The Relationship Between Cd317 Expression and Prognostic Markers Cd38 in Patients With Chronic Lymphocytic Leukemia
2017 · PAMUKÇUOĞLU, MERVE, UÇAR, MEHMET ALİ, et al. · AYBU AVESIS
Ibrutınıb experıence ın relapsedrefractory mantle cell lyphoma
2017 · DAĞDAŞ, SİMTEN, pamukcuoglu, merve, et al. · AYBU AVESIS
Nivolumab experience in refracter hodgkın lymphoma
2017 · Ceran, Funda, urlu, Selin Merih, et al. · AYBU AVESIS
Works count: 28
Citation count: 23
H-index: 3
I10-index:
Year
Topic
Type